aclacinomycin has been researched along with Cardiac Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Applefeld, MM; Bulkley, BH; Grochow, LB; Mader, LC; Taylor, AL; Wiernik, PH | 1 |
| Sazuka, Y; Takino, Y; Tanizawa, H | 1 |
2 other study(ies) available for aclacinomycin and Cardiac Diseases
| Article | Year |
|---|---|
Acute anthracycline cardiotoxicity. Comparative morphologic study of three analogues.
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Cell Nucleus; Chemotherapy, Cancer, Regional Perfusion; Cytoplasm; Daunorubicin; Heart; Heart Diseases; Myocardium; Naphthacenes; Rabbits; Time Factors | 1984 |
Effect of adriamycin on DNA, RNA and protein biosyntheses in mouse tissues, in connection with its cardiotoxicity.
Topics: Aclarubicin; Animals; Carcinoma, Ehrlich Tumor; Daunorubicin; DNA; Doxorubicin; Glutathione Peroxidase; Heart Diseases; Kidney; Lipid Peroxidation; Liver; Lung; Male; Mice; Myocardium; Protein Biosynthesis; RNA | 1989 |